glp-1 agonists cancer risk of pancreatic associated with receptor agonist therapy Could GLP-1 medications help slow
Description
doi: 10.2147/CPAA.S276085
doi: 10.1038/oby.2010.147
We earn revenue from product sales linked in this article
Kristian Brock, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, B15 2TT, UK
